Human Papillomavirus on Oral Tissue, Saliva and Serum
CDHPOTSS
Comparison of Detection of Human Papillomavirus on Tissue, Saliva and Serum
1 other identifier
observational
80
1 country
1
Brief Summary
Human papillomavirus (HPV) is one of the most prevalent infections in the world with several millions of new cases diagnosed yearly. Oral HPV infection may be associated with different diseases of oral cavities including some cases of oropharyngeal cancer. The aim of this report is to detect the presence of HPV DNA in samples of biopsies, oral swabs, saliva and serum of patient with oral squamous cell carcinoma (OSCC) and controls. We hoped to find there is correlation among the presence of HPV DNA in the several biological materials and if it is possible to use the saliva as screening to HPV DNA detection. The presence of tumor HPV DNA in blood may be of diagnostic and prognostic value.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started May 2009
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2010
CompletedFirst Submitted
Initial submission to the registry
January 5, 2010
CompletedFirst Posted
Study publicly available on registry
January 6, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2010
CompletedMarch 26, 2013
March 1, 2013
8 months
January 5, 2010
March 23, 2013
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
DNA HPV status (positive/negative)
six months
Secondary Outcomes (1)
clinical and pathological characteristics
six months
Study Arms (2)
GROUP OSCC
The study group is composed by patients with a condition that requires a procedure/surgery for oral squamous cell carcinoma treatment. INTERVENTIONS: Collect blood, saliva and oral tissue.
CONTROL GROUP
Group without oral squamous cell carcinoma but with a condition that requires prosthetic procedure/surgery. INTERVENTIONS: Collect blood, saliva and oral tissue.
Eligibility Criteria
university dental care clinic patients with or without a condition
You may qualify if:
- Pathological diagnosis of squamous cell carcinoma, presented lesions with primary site in the mouth or oropharynx;
- Matched controls without a condition.
You may not qualify if:
- Patients that received radiotherapy.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Glauco Issamu Miyahara
Araçatuba, São Paulo, 16015050, Brazil
Related Publications (2)
Bodaghi S, Wood LV, Roby G, Ryder C, Steinberg SM, Zheng ZM. Could human papillomaviruses be spread through blood? J Clin Microbiol. 2005 Nov;43(11):5428-34. doi: 10.1128/JCM.43.11.5428-5434.2005.
PMID: 16272465BACKGROUNDZhao M, Rosenbaum E, Carvalho AL, Koch W, Jiang W, Sidransky D, Califano J. Feasibility of quantitative PCR-based saliva rinse screening of HPV for head and neck cancer. Int J Cancer. 2005 Nov 20;117(4):605-10. doi: 10.1002/ijc.21216.
PMID: 15929076BACKGROUND
Biospecimen
This biospecimens will be retained: whole blood, exfoliated cells, saliva and formalin-fixed paraffin-embedded tissues.
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Adriana Demathe, PhD
UNESP Dental School
- STUDY DIRECTOR
Glauco I Miyahara, PhD
UNESP Dental School
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- PhD Adriana Demathe
Study Record Dates
First Submitted
January 5, 2010
First Posted
January 6, 2010
Study Start
May 1, 2009
Primary Completion
January 1, 2010
Study Completion
December 1, 2010
Last Updated
March 26, 2013
Record last verified: 2013-03